CDC turmoil deepens as Monarez disputes reports of resignation
Attorneys for Monarez said that she “has neither resigned nor received notification from the White House that she has been fired” and vowed she “will not resign.”
Attorneys for Monarez said that she “has neither resigned nor received notification from the White House that she has been fired” and vowed she “will not resign.”
Nuvaxovid's approval comes as officials prepare for another vaccination season, with manufacturers updating their shots to target circulating variants.
The survey showed a rise in consumer references to inflation and tariffs, underscoring persistent anxiety over household budgets.
With more than 125 patents, private-label collaborations, and global distribution, the company highlighted its role as a leader in cryotherapy during its TSE debut.
Grannum, who previously held leadership roles at Campbell’s and Reckitt, brings more than 15 years of international experience in sales and strategy.
HDA President and CEO Chester “Chip” Davis, Jr. said the achievement represents progress beyond regulatory compliance.
Gen Z has grown far less likely to see tariffs as beneficial for the economy or their personal finances, according to the August survey.
While the Asia-Pacific region is expected to be the fastest-growing, North America remains a key and profitable market.
The cuts follow Kroger’s decision to close around 60 underperforming stores by 2026.
Lilly’s oral GLP-1 pill helped patients lose 22 pounds and lower A1C in a Phase 3 trial, with global filings planned this year.
The departure marks the end of Walgreens’ more than decade-long run in the S&P 500 index, reflecting its struggles to adapt to changing healthcare and retail markets.
This marks the first time WCC Biomedical is presenting at a U.S. trade show.
Startup founded by twin brothers grows from caregiving roots to $35 million in sales and prepares for retail expansion, while addressing urgent needs highlighted in AARP’s latest caregiving report.
With the U.S. supplement market continuing to expand, manufacturers are under increasing pressure to substantiate claims.
Express Scripts’ court fight with Martella Pharmacies underscores increasing scrutiny of PBMs and concerns over rural pharmacy closures.
A new ACS study shows that climate disasters have impacted nearly two-thirds of U.S. drug manufacturing sites, highlighting increasing risks of medication shortages.